Rxsight Stock Analysis

Rxsight Stock Analysis Notes

About 89.0% of the company shares are owned by institutional investors. The book value of Rxsight was at this time reported as 6.89. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Rxsight recorded a loss per share of 0.81. The entity had not issued any dividends in recent years. RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses used in cataract surgery in the United States and internationally. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California. Rxsight operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 221 people. To find out more about Rxsight contact Ronald MD at 949 521 7830 or learn more at https://www.rxsight.com.

Rxsight Investment Alerts

Rxsight Upcoming and Recent Events

Rxsight Largest EPS Surprises

View All Earnings Estimates

Rxsight Environmental, Social, and Governance (ESG) Scores

Rxsight Stock Institutional Investors

Note, although Rxsight's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Rxsight Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.37 B.

Rxsight Profitablity

The company has Profit Margin (PM) of (0.24) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.26) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.26.

Management Efficiency

Rxsight has return on total asset (ROA) of (0.0992) % which means that it has lost $0.0992 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1399) %, meaning that it created substantial loss on money invested by shareholders. Rxsight's management efficiency ratios could be used to measure how well Rxsight manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.29 in 2025. Return On Capital Employed is likely to drop to -0.29 in 2025. Change To Liabilities is likely to gain to about 6.6 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 15.2 M in 2025.

Technical Drivers

As of the 1st of February, Rxsight holds the Coefficient Of Variation of (588.24), variance of 10.37, and Risk Adjusted Performance of (0.14). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rxsight, as well as the relationship between them.

Rxsight Price Movement Analysis

Rxsight Insider Trading Activities

Rxsight Outstanding Bonds

Rxsight Predictive Daily Indicators

Rxsight Corporate Filings

Rxsight Forecast Models

Rxsight's time-series forecasting models are one of many Rxsight's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Rxsight's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Rxsight prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Rxsight shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Rxsight. By using and applying Rxsight Stock analysis, traders can create a robust methodology for identifying Rxsight entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Rxsight analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Rxsight analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Rxsight stock analysis indicators help investors evaluate how Rxsight stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Rxsight shares will generate the highest return on investment. By understating and applying Rxsight stock analysis, traders can identify Rxsight position entry and exit signals to maximize returns.

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.